Coherus Biosciences | Creditori Commerciali

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




Creditori Commerciali Cambiamento Data
AbbVie USD 32.25B 1.2B 2025-06
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Akebia Therapeutics USD 10.09M 1.47M 2025-09
ALKERMES USD 68M 31.21M 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Amarin USD 36.71M 8M 2025-09
Amgen USD 20.89B 1.25B 2025-12
Baxter International USD 953M 42M 2025-09
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 24.89M 12.73M 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Fujifilm JPY 308.06B 17.41B 2025-12
Gilead Sciences USD 808M 226M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Merck USD 4.15B 102M 2025-09
Myriad Genetics USD 31.8M 900K 2025-09
Pacira USD 17.69M 12.44M 2025-09
Perrigo USD 469.7M 19.3M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09
Xencor USD 9.08M 9.45M 2025-09
Zoetis USD 410M 98M 2025-09


Coherus Biosciences Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.